MedPath

Comparison of dexmedetomidine(Precedex premix)-remifentanil(Remiva) versus remimazolam(Byfavo)-remifentanil(Remiva) for procedural sedation during endoscopic submucosal dissection of gastric tumor

Not Applicable
Recruiting
Conditions
Neoplasms
Registration Number
KCT0008517
Lead Sponsor
Konkuk University Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
68
Inclusion Criteria

1. Those who visit the gastroenterology department of the main hospital and become indicators of gastric tumor endoscopic submucosal dissection
2. ECOG 2 or less

Exclusion Criteria

1. Subjects who disagreed with the study
2. Subjects under the age of 20 or those over the age of 80
3. Persons subject to severe mental quality
4. Pregnant women and those who are planning to get pregnant
5. Those with terminal renal failure or creatine clearance of 30ml/min or less
6. ECOG 3 or higher

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Target Percentage of subjects who do not need a rescue sedative to maintain sedation level, procedure time, complete resection, interfering action during procedure, recoevery time
Secondary Outcome Measures
NameTimeMethod
complication during procedure, recovery room, procedure related complication
© Copyright 2025. All Rights Reserved by MedPath